Hide and tick: a One Health approach to survey and reduce the disease burden of tick-borne diseases

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.015E+13

Grant search

Key facts

  • Disease

    Tick-Borne Encephalitis
  • Start & end year

    2024.0
    2028.0
  • Known Financial Commitments (USD)

    $0
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    Dr. K Kerkhof
  • Research Location

    Netherlands
  • Lead Research Institution

    Rijksinstituut voor Volksgezondheid en Milieu
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Ticks transmit Borrelia burgdorferi s.l., the cause of Lyme borreliosis (LB), and tick-borne encephalitis virus. There is proof of ticks transmitting B. miyamotoi, Anaplasma phagocytophilum, Babesia microti and other tick-borne pathogens (TBPs). The human disease burden of these pathogens in the Netherlands is not well known and the pathogenicity after infection and influence on the course of LB has not been fully demonstrated. Serology is crucial to understand the occurrence and exposure to TBPs in animals and humans. Aim Thus, our goal is to assess the contribution of TBP infections to acute and long-term symptoms in patients with or without LB in the Netherlands. The current serological tests are time consuming, insensitive and non-specific, thus many TBP infections remain undetected. (Expected) results By screening existing cohorts with our novel multiplex immunoassay, we will facilitate early detection and treatment of TBP cases. Thereby, potentially reducing the disease burden of LB and other TBPs.